IS2064B - Öragna form tetrahýdrópýrídínafleiðu - Google Patents
Öragna form tetrahýdrópýrídínafleiðuInfo
- Publication number
- IS2064B IS2064B IS5077A IS5077A IS2064B IS 2064 B IS2064 B IS 2064B IS 5077 A IS5077 A IS 5077A IS 5077 A IS5077 A IS 5077A IS 2064 B IS2064 B IS 2064B
- Authority
- IS
- Iceland
- Prior art keywords
- microfinite
- tetrahydropyridine derivative
- tetrahydropyridine
- derivative
- microfinite form
- Prior art date
Links
- VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical class C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9615905A FR2757510B1 (fr) | 1996-12-23 | 1996-12-23 | Forme microparticulaire d'un derive de tetrahydropyridine |
| PCT/FR1997/002394 WO1998028272A1 (fr) | 1996-12-23 | 1997-12-23 | Forme microparticulaire d'un derive de tetrahydropyridine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS5077A IS5077A (is) | 1999-06-10 |
| IS2064B true IS2064B (is) | 2005-11-15 |
Family
ID=9499044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5077A IS2064B (is) | 1996-12-23 | 1999-06-10 | Öragna form tetrahýdrópýrídínafleiðu |
Country Status (38)
| Country | Link |
|---|---|
| US (4) | US20020028247A1 (de) |
| EP (1) | EP0950051B1 (de) |
| JP (2) | JP4422214B2 (de) |
| KR (1) | KR100455797B1 (de) |
| CN (1) | CN1088698C (de) |
| AR (1) | AR009673A1 (de) |
| AT (1) | ATE250032T1 (de) |
| AU (1) | AU730302B2 (de) |
| BR (1) | BR9714177A (de) |
| CA (1) | CA2275593C (de) |
| CO (1) | CO4920213A1 (de) |
| CZ (1) | CZ294272B6 (de) |
| DE (1) | DE69724999T2 (de) |
| DK (1) | DK0950051T3 (de) |
| DZ (1) | DZ2386A1 (de) |
| EE (1) | EE04112B1 (de) |
| EG (1) | EG24749A (de) |
| ES (1) | ES2207758T3 (de) |
| FR (1) | FR2757510B1 (de) |
| HK (1) | HK1024000A1 (de) |
| HU (1) | HU224348B1 (de) |
| IL (1) | IL129937A (de) |
| IN (1) | IN186977B (de) |
| IS (1) | IS2064B (de) |
| MY (1) | MY126298A (de) |
| NO (1) | NO311569B1 (de) |
| NZ (1) | NZ336129A (de) |
| PL (1) | PL190098B1 (de) |
| PT (1) | PT950051E (de) |
| RU (1) | RU2193031C2 (de) |
| SI (1) | SI0950051T1 (de) |
| SK (1) | SK283917B6 (de) |
| TR (1) | TR199901362T2 (de) |
| TW (1) | TW534820B (de) |
| UA (1) | UA66776C2 (de) |
| WO (1) | WO1998028272A1 (de) |
| YU (1) | YU49427B (de) |
| ZA (1) | ZA9711579B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100579514C (zh) * | 2001-07-06 | 2010-01-13 | 生命周期药物公司 | 通过受控制的凝聚而制备颗粒物的方法以及提高生物利用度的方法 |
| BE1015641A4 (fr) * | 2003-05-26 | 2005-07-05 | Mariani Jean Paul | Micronisation 70. |
| RU2472490C1 (ru) * | 2011-08-05 | 2013-01-20 | Открытое акционерное общество "Биосинтез" | Средство для лечения кожных гнойных инфекций, составы и способы получения |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US562883A (en) * | 1896-06-30 | Thill-coupling | ||
| FR2531707A1 (fr) * | 1982-08-16 | 1984-02-17 | Midy Spa | Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques |
| US4826689A (en) * | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
| FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
| FR2639226B1 (fr) * | 1988-11-18 | 1993-11-05 | Sanofi | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs |
| FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
| JP3523254B2 (ja) * | 1992-10-26 | 2004-04-26 | シュヴァルツ・ファルマ・アクチエンゲゼルシャフト | マイクロカプセルの製造方法 |
| US5560932A (en) * | 1995-01-10 | 1996-10-01 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents |
| US5662883A (en) * | 1995-01-10 | 1997-09-02 | Nanosystems L.L.C. | Microprecipitation of micro-nanoparticulate pharmaceutical agents |
| US6489334B2 (en) * | 1996-12-23 | 2002-12-03 | Sanofi-Synthelabo | Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms |
| FR2763847B1 (fr) * | 1997-05-28 | 2003-06-06 | Sanofi Sa | Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1 |
| US20020147216A1 (en) * | 2000-01-31 | 2002-10-10 | Yuhong Zhou | Mucin synthesis inhibitors |
-
1996
- 1996-12-23 FR FR9615905A patent/FR2757510B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-19 AR ARP970106030A patent/AR009673A1/es not_active Application Discontinuation
- 1997-12-22 DZ DZ970236A patent/DZ2386A1/xx active
- 1997-12-22 MY MYPI97006232A patent/MY126298A/en unknown
- 1997-12-23 AT AT97952987T patent/ATE250032T1/de active
- 1997-12-23 BR BR9714177-1A patent/BR9714177A/pt not_active Application Discontinuation
- 1997-12-23 DK DK97952987T patent/DK0950051T3/da active
- 1997-12-23 UA UA99063520A patent/UA66776C2/uk unknown
- 1997-12-23 DE DE69724999T patent/DE69724999T2/de not_active Expired - Lifetime
- 1997-12-23 SI SI9730592T patent/SI0950051T1/xx unknown
- 1997-12-23 CZ CZ19992291A patent/CZ294272B6/cs not_active IP Right Cessation
- 1997-12-23 IL IL12993797A patent/IL129937A/en not_active IP Right Cessation
- 1997-12-23 EE EEP199900263A patent/EE04112B1/xx not_active IP Right Cessation
- 1997-12-23 ES ES97952987T patent/ES2207758T3/es not_active Expired - Lifetime
- 1997-12-23 AU AU56685/98A patent/AU730302B2/en not_active Ceased
- 1997-12-23 JP JP52848298A patent/JP4422214B2/ja not_active Expired - Fee Related
- 1997-12-23 NZ NZ336129A patent/NZ336129A/xx not_active IP Right Cessation
- 1997-12-23 KR KR10-1999-7005372A patent/KR100455797B1/ko not_active IP Right Cessation
- 1997-12-23 TR TR1999/01362T patent/TR199901362T2/xx unknown
- 1997-12-23 YU YU28899A patent/YU49427B/sh unknown
- 1997-12-23 RU RU99116321/04A patent/RU2193031C2/ru not_active IP Right Cessation
- 1997-12-23 PL PL97334276A patent/PL190098B1/pl not_active IP Right Cessation
- 1997-12-23 CA CA002275593A patent/CA2275593C/en not_active Expired - Fee Related
- 1997-12-23 CN CN97180862A patent/CN1088698C/zh not_active Expired - Fee Related
- 1997-12-23 ZA ZA9711579A patent/ZA9711579B/xx unknown
- 1997-12-23 IN IN3767DE1997 patent/IN186977B/en unknown
- 1997-12-23 WO PCT/FR1997/002394 patent/WO1998028272A1/fr active IP Right Grant
- 1997-12-23 EP EP97952987A patent/EP0950051B1/de not_active Expired - Lifetime
- 1997-12-23 CO CO97074790A patent/CO4920213A1/es unknown
- 1997-12-23 HU HU0001181A patent/HU224348B1/hu not_active IP Right Cessation
- 1997-12-23 US US09/331,514 patent/US20020028247A1/en not_active Abandoned
- 1997-12-23 PT PT97952987T patent/PT950051E/pt unknown
- 1997-12-23 EG EG138497A patent/EG24749A/xx active
- 1997-12-23 SK SK829-99A patent/SK283917B6/sk not_active IP Right Cessation
-
1998
- 1998-01-21 TW TW086119619A patent/TW534820B/zh not_active IP Right Cessation
-
1999
- 1999-06-10 IS IS5077A patent/IS2064B/xx unknown
- 1999-06-22 NO NO19993077A patent/NO311569B1/no not_active IP Right Cessation
-
2000
- 2000-05-30 HK HK00103194A patent/HK1024000A1/xx not_active IP Right Cessation
-
2002
- 2002-06-21 US US10/177,384 patent/US20020192292A1/en not_active Abandoned
-
2008
- 2008-06-13 US US12/138,582 patent/US20080255365A1/en not_active Abandoned
-
2009
- 2009-06-10 JP JP2009139083A patent/JP2009280581A/ja active Pending
- 2009-10-05 US US12/573,455 patent/US20100021541A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9507179A (pt) | Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena | |
| ATE207899T1 (de) | 4-hydroxypiperidinderivate | |
| ATE278695T1 (de) | Piperidinderivate | |
| ATE212551T1 (de) | Injizierbare quinolonformulierungen | |
| NO965233D0 (no) | Deacetoksytaksol-derivat | |
| ID16838A (id) | Komposisi dekafluoropentana | |
| ID18300A (id) | Metoda penemperan | |
| DE69706813D1 (de) | 4-Hydroxypiperidinderivate | |
| DE69521745T2 (de) | Diazacycloalkanalkylsulfonamid-derivat | |
| NO970144D0 (no) | Trifluormetylkinolinkarboksylsyre-derivat | |
| IS5077A (is) | Öragna form tetrahýdrópýrídínafleiðu | |
| NO992302D0 (no) | Piperidin-derivater | |
| ID17419A (id) | Komposisi dekafluoropentana | |
| BR9704770A (pt) | Derivados de 1-carba-(detia)-cefalosporina | |
| NO20001778L (no) | Substituerte piperidinderivater | |
| UA25722A (uk) | Формувач сиhхроhізоваhих імпульсів | |
| DE69427775T2 (de) | Dimethylfurancarboxamilid-derivat | |
| FI952000A (fi) | Tiadiatsinonijohdannaisia | |
| FI963726A0 (fi) | Foerfarande foer anordnande av en transaktionsbaserad faktvering i samband med telefontjaenster | |
| DK0705833T3 (da) | DC-89-derivat | |
| DE69633415D1 (de) | Duftstoffvorläufer | |
| FI963490A0 (fi) | Foerbaettring av gasblandningen en cellforming foerbraenningsskaol med passagefront | |
| FI963656A0 (fi) | Foerverkligande av audiokorrektorer med warpade digitalfiltrer | |
| FI964352A0 (fi) | Rengoering av en plattvaermevaexlare med hjaelp av effektultraljud | |
| UA25135A (uk) | Спосіб гастроєюhопластики |